Home » Gilead Sciences to Promote Low-Cost HIV Medicine in Developing World
Gilead Sciences to Promote Low-Cost HIV Medicine in Developing World
Gilead Sciences said it plans to partner with Mylan, Ranbaxy Laboratories and Strides Arcolab to promote access to high-quality, low-cost generic versions of Gilead’s HIV medicine emtricitabine in developing countries.
The Wall Street Journal
The Wall Street Journal
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May